Humana Stock Forecast for 2023 - 2025 - 2030
Updated on 04/22/2024
Humana Stock Forecast and Price Target
The average price target for Humana's stock set by recognized analysts recently is $385.00, which would result in a potential upside of approximately 18.35% if it reached this mark. The estimation is based on a high estimate of $550.00 and a low estimate of $326.00. If you are interested in HUM stock, it is important to also consider its competitors.
18.35% Upside
Humana Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Humana's Price has decreased by 100.00%, going from $338.63 to $0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $555.89 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Humana will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MSFT Stock Forecast | Microsoft Corp | Buy |
18
|
$400.96 | Buy/Sell | $465.63 | 17.04% |
| BRK.A Stock Forecast | Berkshire Hathaway Inc | Outperform |
7
|
$617.28k | Buy/Sell | $621.67k | 4.49% |
| WMT Stock Forecast | Walmart Inc | Outperform |
15
|
$60.14 | Buy/Sell | $179.15 | 9.74% |
| UNH Stock Forecast | UnitedHealth Group | Buy |
16
|
$491.23 | Buy/Sell | $595.09 | 14.41% |
| ELV Stock Forecast | Elevance Health | Buy |
14
|
$532.22 | Buy/Sell | $567.53 | 12.74% |
Humana Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Revenue for Humana has grown by 37.87%, going from $77.16B to $106.37B. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach $110.32B – an increase of 3.71%. Over the next seven years, experts anticipate that Revenue growth for Humana will be 49.32%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CB Stock Forecast | Chubb | Outperform |
8
|
$251.50 | Buy/Sell | $243.68 | 7.36% |
| CI Stock Forecast | The Cigna Group | Outperform |
12
|
$353.18 | Buy/Sell | $354.48 | 9.01% |
| MMC Stock Forecast | Marsh & McLennan Companies | Hold |
9
|
$201.43 | Buy/Sell | $202.82 | 4.25% |
.jpg)
Humana Dividend per Share Forecast for 2023 - 2025 - 2030
Humana's Dividend per Share has grown in the last three years, jumping from $2.50 to $3.54 – an increase of 41.60%. In the next year, analysts predict that Dividend per Share will reach $6.03 – an increase of 70.34%. For the next seven years, the forecast is for Dividend per Share to grow by 72.32%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CVS Stock Forecast | CVS Health | Outperform |
12
|
$69.63 | Buy/Sell | $89.54 | 26.10% |
| HCA Stock Forecast | HCA Healthcare | Outperform |
18
|
$310.31 | Buy/Sell | $319.61 | 10.76% |
| MET Stock Forecast | MetLife | Outperform |
10
|
$71.96 | Buy/Sell | $77.01 | 15.34% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AIG Stock Forecast | American International Group | Outperform |
8
|
$74.96 | Buy/Sell | $76.11 | 10.06% |
| TRV Stock Forecast | The Travelers Companies | Hold |
8
|
$214.27 | Buy/Sell | $215.98 | 5.24% |
| AFL Stock Forecast | Aflac | Hold |
7
|
$83.52 | Buy/Sell | $82.50 | 0.57% |
Humana EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Humana's EBITDA has decreased from $5.25B to $4.93B – a 6.11% drop! For next year, the 6 analysts predict EBITDA of $5.98B, which would mean an increase of 21.37%. Over the next seven years, the pros' prediction is EBITDAof $9.95B, which would mean a seven-year growth forecast of 101.83%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALL Stock Forecast | The Allstate | Outperform |
6
|
$175.41 | Buy/Sell | $168.84 | 7.75% |
| MFC Stock Forecast | Manulife Financial | Outperform |
9
|
C$32.14 | Buy/Sell | C$29.66 | 12.01% |
| CNC Stock Forecast | Centene | Outperform |
11
|
$75.58 | Buy/Sell | $88.33 | 19.08% |
Humana EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Humana has seen a decline in its EBIT, from $4.99B to $4.01B – a 19.51% decrease. In the next year, analysts expect EBIT to reach $5.29B – an increase of 31.72%. For the next seven years, the forecast is for EBIT to grow by 91.40%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PRU Stock Forecast | Prudential Financial | Hold |
8
|
$111.47 | Buy/Sell | $107.07 | 3.17% |
| HIG Stock Forecast | Hartford Financial Services Gr... | Outperform |
18
|
$99.82 | Buy/Sell | $94.55 | 10.20% |
| CAH Stock Forecast | Cardinal Health Inc | Hold |
13
|
$102.83 | Buy/Sell | $108.07 | 11.84% |
Humana EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Humana's EPS has decreased by 100.00%, going from $18.75 to $0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $30.78 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Humana will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MOH Stock Forecast | Molina Healthcare | Outperform |
16
|
$361.87 | Buy/Sell | $393.38 | 15.61% |
| WBA Stock Forecast | Walgreens Boots Alliance Inc | Hold |
11
|
$18.22 | Buy/Sell | $26.06 | 20.75% |
| DVA Stock Forecast | DaVita Inc | Hold |
16
|
$132.52 | Buy/Sell | $108.38 | 0.36% |
.jpg)